{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:25:58Z","timestamp":1794360358077,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000},"content-version":"vor","delay-in-days":121,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-026-01161-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:14:26Z","timestamp":1783930466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of dietary patterns on glycemic and liver enzymes in metabolic dysfunction-associated steatotic liver disease: a network meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Vali","family":"Musazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Faghfouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Morvaridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Shahraki","family":"Jazinaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mahmoudinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Barazandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Shidfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"1","key":"1161_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","volume":"11","author":"DQ Huang","year":"2025","unstructured":"Huang DQ, et al. Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers. 2025;11(1):14.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl","key":"1161_CR2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32-s50.","journal-title":"Clin Mol Hepatol"},{"issue":"11","key":"1161_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin M, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113(11):1649\u201359.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1161_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197\u2013213.","journal-title":"J Obes Metab Syndr"},{"key":"1161_CR5","doi-asserted-by":"crossref","unstructured":"Zhou Z, et al. The association between sedentary behavior and MASLD in overweight and obese adults: investigating the role of inflammatory markers using NHANES data (2017\u2013March 2020). Frontiers in Nutrition. 2025;12.","DOI":"10.3389\/fnut.2025.1579453"},{"key":"1161_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/nu15061483","author":"JD Torres-Pe\u00f1a","year":"2023","unstructured":"Torres-Pe\u00f1a JD, et al. Different dietary approaches, non-alcoholic fatty liver disease and cardiovascular disease: a literature review. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15061483.","journal-title":"Nutrients"},{"issue":"1","key":"1161_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40795-024-00961-8","volume":"10","author":"F Bakhshimoghaddam","year":"2024","unstructured":"Bakhshimoghaddam F, et al. Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies. BMC Nutr. 2024;10(1):153.","journal-title":"BMC Nutr"},{"issue":"4","key":"1161_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/antiox13040480","volume":"13","author":"MM Quetglas-Llabr\u00e9s","year":"2024","unstructured":"Quetglas-Llabr\u00e9s MM, et al. Impact of adherence to the Mediterranean diet on antioxidant status and metabolic parameters in Nafld patients: A 24-month lifestyle intervention study. Antioxidants. 2024;13(4):480.","journal-title":"Antioxidants"},{"issue":"4","key":"1161_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/hepr.14155","volume":"55","author":"F Hasan","year":"2025","unstructured":"Hasan F, et al. Evaluating the impact of the Dietary Approaches to Stop Hypertension diet versus a calorie-restricted diet on metabolic dysfunction-associated steatotic liver disease: A meta-analysis of randomized controlled trials. Hepatol Res. 2025;55(4):515\u201326.","journal-title":"Hepatol Res"},{"issue":"2","key":"1161_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13679-021-00430-4","volume":"10","author":"K Sandby","year":"2021","unstructured":"Sandby K, et al. Efficacy of dietary manipulations for depleting intrahepatic triglyceride content: implications for the management of non-alcoholic fatty liver disease. Curr Obes Rep. 2021;10(2):125\u201333.","journal-title":"Curr Obes Rep"},{"issue":"11","key":"1161_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"1161_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"1161_CR13","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2019013","volume":"41","author":"SR Shim","year":"2019","unstructured":"Shim SR, et al. Network meta-analysis: application and practice using R software. Epidemiol Health. 2019;41:e2019013.","journal-title":"Epidemiol Health"},{"issue":"3","key":"1161_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ije\/dys041","volume":"41","author":"RM Turner","year":"2012","unstructured":"Turner RM, et al. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the cochrane database of systematic reviews. Int J Epidemiol. 2012;41(3):818\u201327.","journal-title":"Int J Epidemiol"},{"key":"1161_CR15","unstructured":"Dias S. Inconsistency in networks of evidence based on randomised controlled trials. 2014: National Institute for Health and Care Excellence (NICE)."},{"issue":"30","key":"1161_CR16","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1002\/sim.6001","volume":"32","author":"J K\u00f6nig","year":"2013","unstructured":"K\u00f6nig J, Krahn U, Binder H. Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons. Stat Med. 2013;32(30):5414\u201329.","journal-title":"Stat Med"},{"issue":"7","key":"1161_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti G, et al. Evaluating the quality of evidence from a network meta-analysis. PLoS ONE. 2014;9(7):e99682.","journal-title":"PLoS ONE"},{"issue":"7109","key":"1161_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"1","key":"1161_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15(1):58.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"1161_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, et al. CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4):e1003082.","journal-title":"PLoS Med"},{"issue":"2","key":"1161_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/nu13020629","volume":"13","author":"M Abbate","year":"2021","unstructured":"Abbate M, et al. Energy expenditure improved risk factors associated with renal function loss in NAFLD and MetS patients. Nutrients. 2021;13(2):629.","journal-title":"Nutrients"},{"issue":"8","key":"1161_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/nu9080870","volume":"9","author":"L Abenavoli","year":"2017","unstructured":"Abenavoli L, et al. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients. 2017;9(8):870.","journal-title":"Nutrients"},{"issue":"1","key":"1161_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.34172\/hpp.2023.10","volume":"13","author":"T Badali","year":"2023","unstructured":"Badali T, et al. The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: a double-blind controlled randomized clinical trial. Health Promotion Perspectives. 2023;13(1):77.","journal-title":"Health Promotion Perspectives"},{"issue":"4","key":"1161_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3748\/wjg.v25.i4.509","volume":"25","author":"M Biolato","year":"2019","unstructured":"Biolato M, et al. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. World J Gastroenterol. 2019;25(4):509.","journal-title":"World J Gastroenterol"},{"key":"1161_CR25","doi-asserted-by":"publisher","DOI":"10.15403\/jgld-197","author":"F de Faria Ghetti","year":"2019","unstructured":"de Faria Ghetti F, et al. Effects of dietary intervention on gut microbiota and metabolic-nutritional profile of outpatients with non-alcoholic steatohepatitis: a randomized clinical trial. J Gastrointestin Liver Dis. 2019. https:\/\/doi.org\/10.15403\/jgld-197.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"6","key":"1161_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/07315724.2018.1445047","volume":"37","author":"M Dinu","year":"2018","unstructured":"Dinu M, et al. A Khorasan wheat-based replacement diet improves risk profile of patients with nonalcoholic fatty liver disease (NAFLD): a randomized clinical trial. J Am Coll Nutr. 2018;37(6):508\u201314.","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"1161_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1017\/S0007114519002769","volume":"123","author":"M Dorosti","year":"2020","unstructured":"Dorosti M, et al. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. Br J Nutr. 2020;123(3):328\u201336.","journal-title":"Br J Nutr"},{"key":"1161_CR28","doi-asserted-by":"publisher","first-page":"1181706","DOI":"10.3389\/fnut.2023.1181706","volume":"10","author":"HL Fateh","year":"2023","unstructured":"Fateh HL, et al. Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials. Front Nutr. 2023;10:1181706.","journal-title":"Front Nutr"},{"issue":"4","key":"1161_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ajcnut.2023.02.008","volume":"117","author":"X Feng","year":"2023","unstructured":"Feng X, et al. Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: a randomized controlled trial. Am J Clin Nutr. 2023;117(4):691\u2013700.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1161_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010066","volume":"13","author":"I Franco","year":"2020","unstructured":"Franco I, et al. Physical activity and low glycemic index Mediterranean diet: main and modification effects on NAFLD score. Results from a randomized clinical trial. Nutrients. 2020;13(1):66.","journal-title":"Nutrients"},{"issue":"4","key":"1161_CR31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/13813455.2021.1890128","volume":"129","author":"N Garousi","year":"2023","unstructured":"Garousi N, et al. Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial. Archives physiol biochemistry. 2023;129(4):975\u201383.","journal-title":"Archives physiol biochemistry"},{"issue":"6","key":"1161_CR32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/liv.15264","volume":"42","author":"ES George","year":"2022","unstructured":"George ES, et al. Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial. Liver Int. 2022;42(6):1308\u201322.","journal-title":"Liver Int"},{"key":"1161_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01502-w","volume":"20","author":"F Haidari","year":"2020","unstructured":"Haidari F, et al. A hypocaloric high-protein diet supplemented with \u03b2-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial. BMC Gastroenterol. 2020;20:1\u201310.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"1161_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.14309\/ajg.0000000000001885","volume":"117","author":"K He","year":"2022","unstructured":"He K, et al. A freshwater fish-based diet alleviates liver steatosis by modulating gut microbiota and metabolites: a clinical randomized controlled trial in Chinese participants with nonalcoholic fatty liver disease. Am J Gastroenterol. 2022;117(10):1621\u201331.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1161_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100256","volume":"3","author":"M Holmer","year":"2021","unstructured":"Holmer M, et al. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet\u2013a randomised controlled trial. JHEP reports. 2021;3(3):100256.","journal-title":"JHEP reports"},{"issue":"7\u20138","key":"1161_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.nut.2013.11.008","volume":"30","author":"AH Kani","year":"2014","unstructured":"Kani AH, et al. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial. Nutrition. 2014;30(7\u20138):814\u201321.","journal-title":"Nutrition"},{"issue":"2","key":"1161_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1017\/S000711451800137X","volume":"120","author":"CN Katsagoni","year":"2018","unstructured":"Katsagoni CN, et al. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. Br J Nutr. 2018;120(2):164\u201375.","journal-title":"Br J Nutr"},{"issue":"10","key":"1161_CR38","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/nu11102543","volume":"11","author":"BA Marin-Alejandre","year":"2019","unstructured":"Marin-Alejandre BA, et al. The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled trial. Nutrients. 2019;11(10):2543.","journal-title":"Nutrients"},{"issue":"5","key":"1161_CR39","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.30076","volume":"68","author":"C Properzi","year":"2018","unstructured":"Properzi C, et al. Ad libitum Mediterranean and low\u2010fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatol. 2018;68(5):1741\u201354.","journal-title":"Hepatol"},{"issue":"4","key":"1161_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/liv.12990","volume":"36","author":"M RazaviZade","year":"2016","unstructured":"RazaviZade M, et al. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int. 2016;36(4):563\u201371.","journal-title":"Liver Int"},{"issue":"1","key":"1161_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu13010015","volume":"13","author":"D Ristic-Medic","year":"2020","unstructured":"Ristic-Medic D, et al. Calorie-restricted Mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease. Nutrients. 2020;13(1):15.","journal-title":"Nutrients"},{"issue":"1","key":"1161_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12986-023-00733-4","volume":"20","author":"F Rooholahzadegan","year":"2023","unstructured":"Rooholahzadegan F, et al. The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial. Nutr Metab. 2023;20(1):11.","journal-title":"Nutr Metab"},{"issue":"1","key":"1161_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","volume":"59","author":"MC Ryan","year":"2013","unstructured":"Ryan MC, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138\u201343.","journal-title":"J Hepatol"},{"issue":"1","key":"1161_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00394-023-03221-w","volume":"63","author":"AA Sangouni","year":"2024","unstructured":"Sangouni AA, et al. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Eur J Nutr. 2024;63(1):95\u2013105.","journal-title":"Eur J Nutr"},{"key":"1161_CR45","doi-asserted-by":"publisher","first-page":"1426551","DOI":"10.3389\/fnut.2024.1426551","volume":"11","author":"SP Mambrini","year":"2024","unstructured":"Mambrini SP, et al. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Front Nutr. 2024;11:1426551.","journal-title":"Front Nutr"},{"key":"1161_CR46","doi-asserted-by":"crossref","unstructured":"Njei B, et al. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis of randomized controlled trials. Cureus. 2024;16 10.","DOI":"10.7759\/cureus.71366"},{"issue":"3","key":"1161_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.750","volume":"9","author":"M Dankers","year":"2021","unstructured":"Dankers M, et al. Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals\u2019 preferences. Pharmacol Res Perspect. 2021;9(3):e00750.","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"1161_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13622","volume":"52","author":"A Karkucinska-Wieckowska","year":"2022","unstructured":"Karkucinska-Wieckowska A, et al. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. Eur J Clin Invest. 2022;52(3):e13622.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"1161_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229753","volume":"15","author":"S Schomaker","year":"2020","unstructured":"Schomaker S, et al. Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments. PLoS ONE. 2020;15(5):e0229753.","journal-title":"PLoS ONE"},{"key":"1161_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11906-010-0168-5","volume":"13","author":"AL Hinderliter","year":"2011","unstructured":"Hinderliter AL, et al. The DASH diet and insulin sensitivity. Curr Hypertens Rep. 2011;13:67\u201373.","journal-title":"Curr Hypertens Rep"},{"key":"1161_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-7075-11-53","volume":"11","author":"DH Pesta","year":"2014","unstructured":"Pesta DH, Samuel VT. A high-protein diet for reducing body fat: mechanisms and possible caveats. Nutr Metab. 2014;11:1\u20138.","journal-title":"Nutr Metab"},{"issue":"10","key":"1161_CR52","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/oby.22964","volume":"28","author":"MP Moore","year":"2020","unstructured":"Moore MP, et al. A fad too far? Dietary strategies for the prevention and treatment of NAFLD. Obesity. 2020;28(10):1843\u201352.","journal-title":"Obesity"},{"issue":"4","key":"1161_CR53","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3748\/wjg.v21.i4.1099","volume":"21","author":"L-X Qiu","year":"2015","unstructured":"Qiu L-X, Chen T. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World J Gastroenterol: WJG. 2015;21(4):1099.","journal-title":"World J Gastroenterol: WJG"},{"key":"1161_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113127","volume":"151","author":"J Pan","year":"2022","unstructured":"Pan J, et al. Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomed Pharmacother. 2022;151:113127.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1161_CR55","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1038\/s41598-025-88773-z","volume":"15","author":"M Shafiee","year":"2025","unstructured":"Shafiee M, et al. Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial. Sci Rep. 2025;15(1):4463.","journal-title":"Sci Rep"},{"issue":"6","key":"1161_CR56","doi-asserted-by":"publisher","first-page":"566.e1","DOI":"10.1016\/j.amjmed.2010.11.030","volume":"124","author":"VR Krishnamurthy","year":"2011","unstructured":"Krishnamurthy VR, et al. Associations of serum alkaline phosphatase with metabolic syndrome and mortality. American J Med. 2011;124(6):566.e1-566.e7.","journal-title":"American J Med"},{"issue":"1","key":"1161_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12986-023-00733-4","volume":"20","author":"F Rooholahzadegan","year":"2023","unstructured":"Rooholahzadegan F, et al. The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial. Nutr Metab (Lond). 2023;20(1):11.","journal-title":"Nutr Metab (Lond)"},{"key":"1161_CR58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2020.02.004","volume":"150","author":"A Aboonabi","year":"2020","unstructured":"Aboonabi A, Aboonabi A. Anthocyanins reduce inflammation and improve glucose and lipid metabolism associated with inhibiting nuclear factor-kappaB activation and increasing PPAR-\u03b3 gene expression in metabolic syndrome subjects. Free Radical Biol Med. 2020;150:30\u20139.","journal-title":"Free Radical Biol Med"},{"key":"1161_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nutres.2023.09.005","volume":"119","author":"A Reddy","year":"2023","unstructured":"Reddy A, et al. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: the MEDINA randomized controlled trial. Nutr Res. 2023;119:98\u2013108.","journal-title":"Nutr Res"},{"issue":"7","key":"1161_CR60","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/nu17071214","volume":"17","author":"G Mercurio","year":"2025","unstructured":"Mercurio G, et al. Mitochondria at the crossroads: linking the mediterranean diet to metabolic health and non-pharmacological approaches to NAFLD. Nutrients. 2025;17(7):1214.","journal-title":"Nutrients"},{"issue":"1","key":"1161_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/nu17010143","volume":"17","author":"S Hamamah","year":"2024","unstructured":"Hamamah S, Iatcu OC, Covasa M. Dietary influences on gut microbiota and their role in metabolic dysfunction-associated steatotic liver disease (MASLD). Nutrients. 2024;17(1):143.","journal-title":"Nutrients"},{"issue":"18","key":"1161_CR62","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3390\/foods11182863","volume":"11","author":"R-G Xiong","year":"2022","unstructured":"Xiong R-G, et al. Health benefits and side effects of short-chain fatty acids. Foods. 2022;11(18):2863.","journal-title":"Foods"},{"key":"1161_CR65","doi-asserted-by":"crossref","unstructured":"Lindqvist, C., et al., Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: secondary analysis of a randomized controlled trial. Nutrition, 2023. 110: p. 111982.","DOI":"10.1016\/j.nut.2023.111982"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01161-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:03:11Z","timestamp":1794358991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1186\/s12986-026-01161-w","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study didn\u2019t receive any external funding.","order":3,"name":"Ethics","label":"Source of support","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}